The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

Ayşe Karataş Umit Yavuz Malkan Mustafa Velet Haluk Demİroğlu Yahya Büyükaşık Gülçin Telli Dizman Ahmet Çagkan Inkaya Batuhan Erdoğdu Olgu Erkin Çinar Elifcan Aladag Salih Aksu İbrahim Celallettin Haznedaroğlu Osman Ilhami Özcebe Nilgün Sayınalp Hakan Goker

Published in: Turkish journal of medical sciences (2021)

It can be concluded that mortality of HSCT recipients is lower in patients whose primary disease is in remission compared to ones that are not in remission. Further studies with larger group patients are needed in order to delineate the effects of COVID-19 on HSCT patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
coronavirus disease
sars cov
peritoneal dialysis
prognostic factors
rheumatoid arthritis
patient reported outcomes
risk factors
cardiovascular events
ulcerative colitis
kidney transplantation
hematopoietic stem cell